Literature DB >> 10208936

Role of the leukocyte function antigen-1 conformational state in the process of human immunodeficiency virus type 1-mediated syncytium formation and virus infection.

J F Fortin1, B Barbeau, H Hedman, E Lundgren, M J Tremblay.   

Abstract

Human immunodeficiency virus type 1 (HIV-1)-mediated syncytium formation is recognized as being highly dependent on intercellular adhesion molecule (ICAM)-1-leukocyte function-associated molecule 1 (LFA)-1 interaction, whereas the process of infection with cell-free virions is independent of such complementary interaction. Our group has recently demonstrated that an antibody-mediated induction of the high affinity state of LFA-1 for ICAM-1 renders target T cells more prone to HIV-1-dependent syncytium formation and infection by ICAM-1-bearing virions. To further substantiate these results, we made use of mutant cell lines expressing LFA-1 in either a low (parental HPB-ALL and HAmut) or a high affinity state for ICAM-1 (HAP4) and compared syncytium formation and virus infection. Cells expressing the activated form of LFA-1 were found to be more susceptible to HIV-1-induced syncytium formation and to infection by ICAM-1-bearing HIV-1 particles. The observed increase was solely due to the LFA-1 activation state because it was abrogated by anti-LFA-1 or anti-ICAM-1 antibodies and not due to variations in surface expression of LFA-1, CD4, or the chemokine coreceptor CXCR4. However, a linear relation was seen between the level of CXCR4 surface expression and susceptibility to syncytium formation/virus infection when ICAM-1-LFA-1 interaction was either absent (i.e., infection with ICAM-1-negative virions) or abrogated (treatment with anti-LFA-1 or anti-ICAM-1 antibodies). These results emphasize the important role of the LFA-1 activation state with respect to virus-induced syncytium formation and HIV-1 infection. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10208936     DOI: 10.1006/viro.1999.9687

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  14 in total

1.  Overactivation of plasmacytoid dendritic cells inhibits antiviral T-cell responses: a model for HIV immunopathogenesis.

Authors:  Adriano Boasso; Caroline M Royle; Spyridon Doumazos; Veronica N Aquino; Mara Biasin; Luca Piacentini; Barbara Tavano; Dietmar Fuchs; Francesco Mazzotta; Sergio Lo Caputo; Gene M Shearer; Mario Clerici; David R Graham
Journal:  Blood       Date:  2011-09-19       Impact factor: 22.113

2.  Rapid dissociation of HIV-1 from cultured cells severely limits infectivity assays, causes the inactivation ascribed to entry inhibitors, and masks the inherently high level of infectivity of virions.

Authors:  Emily J Platt; Susan L Kozak; James P Durnin; Thomas J Hope; David Kabat
Journal:  J Virol       Date:  2009-12-30       Impact factor: 5.103

3.  Unique monoclonal antibody recognizing the third extracellular loop of CXCR4 induces lymphocyte agglutination and enhances human immunodeficiency virus type 1-mediated syncytium formation and productive infection.

Authors:  R Tanaka; A Yoshida; T Murakami; E Baba; J Lichtenfeld; T Omori; T Kimura; N Tsurutani; N Fujii; Z X Wang; S C Peiper; N Yamamoto; Y Tanaka
Journal:  J Virol       Date:  2001-12       Impact factor: 5.103

4.  LFA-1 expression on target cells promotes human immunodeficiency virus type 1 infection and transmission.

Authors:  C E Hioe; P C Chien; C Lu; T A Springer; X H Wang; J Bandres; M Tuen
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

5.  Presence of host ICAM-1 in laboratory and clinical strains of human immunodeficiency virus type 1 increases virus infectivity and CD4(+)-T-cell depletion in human lymphoid tissue, a major site of replication in vivo.

Authors:  Salim Bounou; Jacques E Leclerc; Michel J Tremblay
Journal:  J Virol       Date:  2002-02       Impact factor: 5.103

6.  Interaction between the cytoplasmic domain of ICAM-1 and Pr55Gag leads to acquisition of host ICAM-1 by human immunodeficiency virus type 1.

Authors:  Yannick Beauséjour; Michel J Tremblay
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

7.  Statin compounds reduce human immunodeficiency virus type 1 replication by preventing the interaction between virion-associated host intercellular adhesion molecule 1 and its natural cell surface ligand LFA-1.

Authors:  Jean-François Giguère; Michel J Tremblay
Journal:  J Virol       Date:  2004-11       Impact factor: 5.103

8.  Adhesion molecule interactions facilitate human immunodeficiency virus type 1-induced virological synapse formation between T cells.

Authors:  Clare Jolly; Ivonne Mitar; Quentin J Sattentau
Journal:  J Virol       Date:  2007-10-03       Impact factor: 5.103

9.  Simultaneous cell-to-cell transmission of human immunodeficiency virus to multiple targets through polysynapses.

Authors:  Dominika Rudnicka; Jérôme Feldmann; Françoise Porrot; Steve Wietgrefe; Stéphanie Guadagnini; Marie-Christine Prévost; Jérôme Estaquier; Ashley T Haase; Nathalie Sol-Foulon; Olivier Schwartz
Journal:  J Virol       Date:  2009-04-15       Impact factor: 5.103

10.  LFA-1 antagonists as agents limiting human immunodeficiency virus type 1 infection and transmission and potentiating the effect of the fusion inhibitor T-20.

Authors:  Mélanie R Tardif; Caroline Gilbert; Sandra Thibault; Jean-François Fortin; Michel J Tremblay
Journal:  Antimicrob Agents Chemother       Date:  2009-08-31       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.